glp-1 obesity drug news today september 29 2025 It's outrageous how much we pay for brand-name drugs in the U.S. An EpiPen is $600 here and just $67 in the U.K. And now that Medicare is covering GLP-1s for weight ADA '26: Lilly's dominance, Pfizer's

TB500 (thymosin beta-4) is known for its role in increasing actin, crucial for cell movement and tissue repair

Sans sucre, sans gluten, sans OGM, sans lactose

64 SEMA has demonstrated clear clinical improvements in MASLD/MASH and allows use beyond the instructions, particularly in patients with T2DM and obesity

Mark Gordons approach to traumatic brain injury and post-concussion syndrome focuses on the biochemical consequences that may persist after a concussion, blast exposure or repetitive head trauma

The temptation to reuse needles is higher

Scarring alopecia, where inflammation destroys follicles permanently, requires different approaches